Mechanisms of Action of Topical Corticosteroids in Psoriasis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Psoriasis is a lifelong, chronic, and immune-mediated systemic disease, which affects approximately 1–3% of the Caucasian population. The different presentations of psoriasis require different approaches to treatment and appropriate prescriptions according to disease severity. The use of topical therapy remains a key component of the management of almost all psoriasis patients, and while mild disease is commonly treated only with topical agents, the use of topical therapy as adjuvant therapy in moderate-to-severe disease may also be helpful. This paper focuses on the cutaneous mechanisms of action of corticosteroids and on the currently available topical treatments, taking into account adverse effects, bioavailability, new combination treatments, and strategies to improve the safety of corticosteroids. It is established that the treatment choice should be tailored to match the individual patient’s needs and his/her expectations, prescribing to each patient the most suitable vehicle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 3×
“The inactivation of MAPKs and also of MAPKinteracting kinase by MKP-1 is due to the inhibition of PLA2 activity mediated by glucocorticoids [32].”
BackgroundInfluentialMechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
Sternberg, E. M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1810 · Cited by 1,064
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
Perretti, M., & D'Acquisto, F. (2009) · Nature Reviews Immunology · doi:10.1038/nri2470 · Cited by 915
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898 · cited 2×
“…acid (broad combination is possible; care must be taken regarding steroid side effects), USA guidelines [6] suggest the use of topical steroids as monotherapy in mild-to-moderate psoriasis or in combination with other topical agents, UV light or systemic agents in moderate-to-severe disease [7].”
BackgroundMcKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805 · cited 4×
“tor complex may interact with nuclear factor-κB leading to its transrepression (NF-κB) [30, 31].”
BackgroundInfluentialGlucocorticoids for Human Skin: New Aspects of the Mechanism of Action
Schäfer-Korting, M., Kleuser, B., Ahmed, M., Höltje, H.-D., & Korting, H. C. (2005) · Skin Pharmacology and Physiology · doi:10.1159/000084907 · Cited by 56
Cited by
Stein Gold, L., Bhatia, N., Tallman, A. M., & Rubenstein, D. S. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.181 · Cited by 48
Balkrishna, A., Nain, P., Chauhan, A., Sharma, N., Gupta, A., Ranjan, R., & Varshney, A. (2020) · Biomolecules · doi:10.3390/biom10020185 · Cited by 48
“Topical therapies used are corticosteroids [24] and retinoids [26], whereas systemic medicines include common first-line drugs like methotrexate [27] and cyclosporin [28].”
Background
Metadata
- Authors
- Uva, L., Miguel, D., Pinheiro, C., Antunes, J., Cruz, D., Ferreira, J., & Filipe, P.
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-16
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- OpenAlex
- W2160096806
- Cited by
- 241
- References
- 8
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms of Action of Topical Corticosteroids in Psoriasis. https://app.cochat.ai/papers/10.1155/2012/561018
- The paper
- Uva, L., Miguel, D., Pinheiro, C., Antunes, J., Cruz, D., Ferreira, J., & Filipe, P. (2012). Mechanisms of Action of Topical Corticosteroids in Psoriasis. International Journal of Endocrinology. https://doi.org/10.1155/2012/561018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.